NEWSKIN Whole Embryonic Layer Anti-Aging Skin Renewal Powde 30 mg/6g
MARITIME PINE, SCHISANDRA CHINENSIS SEED, CENTELLA ASIATICA TRITERPENOIDS · POWDER · Japan Medical Biotechnology Limited
NEWSKIN Whole Embryonic Layer Anti-Aging Skin Renewal Powde is a powder containing maritime pine, schisandra chinensis seed, centella asiatica triterpenoids at 30 mg/6g, taken oral. Manufactured by Japan Medical Biotechnology Limited.
Key Facts
- Brand Name
- NEWSKIN Whole Embryonic Layer Anti-Aging Skin Renewal Powde
- Generic Name
- MARITIME PINE, SCHISANDRA CHINENSIS SEED, CENTELLA ASIATICA TRITERPENOIDS
- NDC Code (Product)
87130-002- Manufacturer
- Japan Medical Biotechnology Limited
- Strength
- 30 mg/6g
- Dosage Form
- POWDER
- Route
- ORAL
- Marketing Status
- Marketing Start
- 10/20/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is NEWSKIN Whole Embryonic Layer Anti-Aging Skin Renewal Powde used for?
NEWSKIN Whole Embryonic Layer Anti-Aging Skin Renewal Powde contains MARITIME PINE, SCHISANDRA CHINENSIS SEED, CENTELLA ASIATICA TRITERPENOIDS. It is a powder taken oral. Consult your doctor for specific uses.
Is NEWSKIN Whole Embryonic Layer Anti-Aging Skin Renewal Powde a controlled substance?
NEWSKIN Whole Embryonic Layer Anti-Aging Skin Renewal Powde is not classified as a controlled substance by the DEA.
What is the generic name for NEWSKIN Whole Embryonic Layer Anti-Aging Skin Renewal Powde?
The generic name for NEWSKIN Whole Embryonic Layer Anti-Aging Skin Renewal Powde is MARITIME PINE, SCHISANDRA CHINENSIS SEED, CENTELLA ASIATICA TRITERPENOIDS. There are no other listed brand versions of MARITIME PINE, SCHISANDRA CHINENSIS SEED, CENTELLA ASIATICA TRITERPENOIDS.
What is the NDC code for NEWSKIN Whole Embryonic Layer Anti-Aging Skin Renewal Powde 30 mg/6g?
The NDC (National Drug Code) for NEWSKIN Whole Embryonic Layer Anti-Aging Skin Renewal Powde 30 mg/6g is 87130-002, listed by Japan Medical Biotechnology Limited.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)